Every budding entrepreneur hopes to become the next Mark Cuban, but, as the saying goes, only the strong survive. In fact, ...

Sanofi SA (SNY) reports robust sales growth driven by Dupixent and vaccines, while planning a significant share buyback to ...

Q4 guidance included expanded metrics for 2025, such as mid to high single-digit sales growth and low double-digit EPS growth, compared to a more cautious outlook in Q3. Management also introduced a ...

Having peers facilitate virtual visits may lead to many more patients with hepatitis C receiving treatment and clearing the ...

New Jersey is experiencing a similar increase in cases and has a TB incidence rate above the national average. While TB isn’t ...

Where some see the academic and athletic cuts as a chance to reorient the troubled university, many others in the SSU ...

Unlike short-lived fixes that merely accelerate metabolism for temporary effect, Lipozem takes a root-cause approach, ...

Q1 2025 Earnings Conference Call February 5, 2025 4:30 PM ETCompany ParticipantsMike Watts - Corporate Vice President, ...

Earnings Call Transcript January 30, 2025 Sanofi misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were ...

SunCoke Energy Inc (SXC) surpasses financial guidance with strong cash flow and shareholder returns, while navigating future market uncertainties.